CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,206 Cr | ₹2,686 Cr | ₹2,177 Cr | ₹1,730 Cr | ₹1,364 Cr |
What is the latest Total Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,206 Cr |
| Mar2024 | ₹2,686 Cr |
| Mar2023 | ₹2,177 Cr |
| Mar2022 | ₹1,730 Cr |
| Mar2021 | ₹1,364 Cr |
How is Total Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,206 Cr | 19.36 | |
| Mar2024 | ₹2,686 Cr | 23.34 | |
| Mar2023 | ₹2,177 Cr | 25.85 | |
| Mar2022 | ₹1,730 Cr | 26.88 | |
| Mar2021 | ₹1,364 Cr | - | |
Compare Total Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹18,852.6 Cr | -5.4% | -7.2% | 21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -5.4% |
-7.2% |
21.4% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses